Cutler Group’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $9K | Sell |
4,200
-400
| -9% | -$857 | ﹤0.01% | 641 |
|
|
2023
Q4 | $9K | Hold |
4,600
| – | – | ﹤0.01% | 1015 |
|
|
2023
Q3 | $5K | Hold |
4,600
| – | – | ﹤0.01% | 1149 |
|
|
2023
Q2 | $7K | Hold |
4,600
| – | – | ﹤0.01% | 1052 |
|
|
2023
Q1 | $9K | Buy |
4,600
+100
| +2% | +$196 | ﹤0.01% | 1018 |
|
|
2022
Q4 | $16K | Sell |
4,500
-1,300
| -22% | -$4.62K | ﹤0.01% | 1162 |
|
|
2022
Q3 | $4K | Sell |
5,800
-1,376
| -19% | -$949 | ﹤0.01% | 1613 |
|
|
2022
Q2 | $5K | Sell |
7,176
-8,200
| -53% | -$5.71K | ﹤0.01% | 1538 |
|
|
2022
Q1 | $13K | Buy |
15,376
+6,010
| +64% | +$5.08K | ﹤0.01% | 1478 |
|
|
2021
Q4 | $75K | Sell |
9,366
-3,434
| -27% | -$27.5K | ﹤0.01% | 1042 |
|
|
2021
Q3 | $107K | Buy |
12,800
+6,100
| +91% | +$51K | ﹤0.01% | 935 |
|
|
2021
Q2 | $45K | Buy |
6,700
+2,500
| +60% | +$16.8K | ﹤0.01% | 1270 |
|
|
2021
Q1 | $27K | Buy |
4,200
+3,900
| +1,300% | +$25.1K | ﹤0.01% | 1373 |
|
|
2020
Q4 | $1K | Hold |
300
| – | – | ﹤0.01% | 1698 |
|
|
2020
Q3 | $1K | Sell |
300
-6,900
| -96% | -$23K | ﹤0.01% | 1608 |
|
|
2020
Q2 | $43K | Buy |
7,200
+3,400
| +89% | +$20.3K | ﹤0.01% | 890 |
|
|
2020
Q1 | $20K | Buy |
+3,800
| New | +$20K | ﹤0.01% | 996 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 1989 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2034 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2060 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2061 |
|